228 matches for your search in the start-up spotlight
rssCitryll has translated a deep understanding of the neutrophil extracellular trap (NET) pathway to therapeutically address its central role in a broad range of inflammatory diseases. With a unique dual mode of action, the company’s lead antibody, CIT-013, has reached the clinic by demonstrating a ...
Accelero Biostructures was founded in 2015 to capitalis e on over 20 years of previous structural genomics and structural biology expertise using high-throughput protein X-ray crystallography. With the development and deployment of new platforms and services, ABS ServicesSM and ABS-OneStepSM, ...
Founded in 2015 as a spin-out from Newcastle University. Newcells Biotech builds in vitro models and services to de-risk and improve clinical translation and drug discovery.
At Affinite, we understand the challenges that scientists face when working with techniques such as ELISA. That’s where our next-generation SPR devices become the solution. With Lensless SPR, you can optimize and validate your surface chemistry preparations in real-time, saving you hours of ...
Blue Whale Materials’ proprietary technology recycles spent lithium-ion batteries to safely reclaim and responsibly supply a high value Blacksand™ product that contains cobalt, nickel, and lithium for the growing electrified economy.
Our Vision: We at Calyxia believe that high-performance and eco-engineered chemical solutions are essential to fight pollution, protect biodiversity, and improve the quality of life for all. Our Mission: To build an advanced and sustainable future for the chemical industry by providing leading ...
BioBTX is a circular chemistry technology developer that makes it possible to replaces fossil resources for biomass & plastic waste. We use these renewable resources for the production of drop-in chemicals and aromatics to enable the production of sustainable and future proof materials. BioBTX ...
Amolyt Pharma is building on its team’s established expertise to deliver life-changing treatments to patients suffering from rare endocrine and related diseases. Amolyt Pharma’s portfolio includes eneboparatide (AZP-3601), a long-acting PTH1 receptor agonist as a potential treatment for ...
NORDTREAT is a Finnish technology company founded in 2015, specializing in the development and production of environmentally friendly, high-performance flame retardants. Utilizing bio-based raw materials, NORDTREAT's products comply with the latest fire protection regulations and have been used ...
Maxterial is a Bay Area technology company dedicated to pioneering advancements in material science, including the commercialization of advanced coatings. Founded in 2015, Maxterial leverages an eco-systemic lean tech approach to develop innovative solutions that protect against wear, heat, and ...